Tag: Oxford
-
Two Jabs a Year: The Life-Changing Asthma Drug Depemokimab
New Hope for Asthma Sufferers: Depemokimab reduces treatment burden In a breakthrough that could redefine how asthma is managed, scientists are reporting that depemokimab, a biologic drug, may offer life-changing relief with just two injections annually. The trials, led by researchers including Ian Pavord of the University of Oxford, position depemokimab as a potent alternative…
-
Depemokimab: A New Era for Asthma with Just Two Annual Injections
Introduction: A potential turning point in asthma care New research into depemokimab, a targeted biologic for asthma, is stirring cautious optimism in clinics and among patients who live with the daily challenges of the condition. Led by Ian Pavord, a professor of respiratory medicine at the University of Oxford, the trials position depemokimab as a…
-
Chrystia Freeland Named CEO of Rhodes Trust: A Historic Oxford Appointment
Chrystia Freeland Becomes CEO of the Rhodes Trust In a landmark leadership move for one of the world’s most storied scholarship programs, Chrystia Freeland has been named Chief Executive Officer of the Rhodes Trust. The appointment places Freeland at the helm of the Oxford-based organization that administers the Rhodes Scholarship, a program with a long…
-
Chrystia Freeland Named CEO of Rhodes Trust
Chrystia Freeland Named CEO of the Rhodes Trust Former deputy prime minister Chrystia Freeland has been appointed the next chief executive officer of the Rhodes Trust, the Oxford-based organization that administers one of the world’s oldest and most prestigious scholarships. The appointment places Freeland at the helm of a program known for shaping leaders across…
-
When Cannabis Went Wrong: A Student’s Journey Through a Breakpoint and Mental Health Risks
Introduction: A normalising of cannabis among young adults Like many middle-class London teens, the author began smoking cannabis at 15, drawn by the idea of a natural, safe buzz and the social perks of drug-using circles. Cannabis was increasingly seen as a harmless rite of passage rather than a potential risk, especially when compared with…
-
Cannabis and Mental Health: A Personal Story of Breakdowns, Anxiety, and the Oxford Experience
From casual use to a mental health crisis Like many young people, I started using cannabis as a safer, more accessible alternative to alcohol. It wasn’t about rebellion or heavy experimentation; it was about fitting in, social ease, and the belief that weed was “natural” and harmless. I was a university student, a Londoner away…
-
Cannabis, College, and Crisis: My Oxford Breakthrough About Mental Health and the Dangers of Skunk
Introduction: A Quiet Descent Like many middle-class London teens, I started smoking cannabis around age 15. It felt preferable to alcohol, which I found unpalatable, and weed offered a pleasant buzz that seemed safer because it was “natural” and easy to obtain. It was something I associated with parties, never with home or isolation. By…
-
Scientists Uncover Carbon’s Key Role in Forming Earth’s Inner Core
Carbon’s Hidden Hand in Earth’s Deep Interior A recent collaborative study by researchers from the University of Oxford, the University of Leeds, and University College London sheds new light on the chemistry that allowed Earth’s inner core to solidify billions of years ago. Published in Nature Communications, the work points to carbon as a critical…
-
Vaccines Against Dementia: New Hope From Existing Shots
Rising Dementia Burden and the Promise of Vaccines Dementia remains a major global health challenge. Current estimates place the number of people living with dementia at more than 55 million worldwide, with nearly 10 million new cases each year. If trends continue, the World Health Organization projects the prevalence could triple by 2050. Dementia is…